Page tree

Date

2018-06-18 20.00 UTC

Objectives

  1. Discuss representation of diagnostic products (to be used as values for susceptibility observables)
  2. Discuss Free(Unbound) and Total substances, remaining questions

Discussion items


ItemDescriptionOwnerNotesAction 
1Welcome & apologies


 

 
2Conflicts of interest
  • None stated
  
3Previous minutes


4Free and Total Substances
  • The current plan is to represent the base substance, the bound and the free substance as three siblings with a "substance X and derivatives" common subsumer.
  • This would support the Observables use cases of allowing querying for substances without regard for "bound-ness", and to distinguish between bound, free, and total.
  • Three patterns for Observables would be:
    • Free X Observable === Observable & component = Free X
    • Bound X Observable === Observable & component = Bound X (or X bound to Y)
    • Total X Observable === Observable & component X (base substance concept)

5Susceptibility
  • Mapping of LOINC component for Susceptibility LOINC terms

  • There will likely be a new "diagnostic product" hierarchy parallel to the medicinal product hierarchy, reusing attributes and patterns from that hierarchy. The priority of this work is currently unknown
    • The new category would need modeling guidance (cf. Clinical Drug (CD) Concept - Pattern 1a, permission needed!). Some of the items that should be considered are as follows (from Farzaneh and Toni):
    • Do we need a new semantic tag?

    • Can the concepts be modelled with a single pattern/template or are there multiple patterns/templates needed?

    • Can we reuse of some of attributes in medicinal product and CDs? Do we need to create new ones?

    • Does the hierarchy require groupers?

    • Do any concepts have strength ranges?

    • If a concept specifies more than one substance, does each substance have an associated strength?

    • See this page for discussion: Diagnostic products

    • Draft editorial guidelines: Editorial Guidelines for Diagnostic Products Used for Susceptibility Testing

  • Daniel Karlsson to update the editorial guidelines for diagnostic products for susceptibility tests and report back at next meeting

6Next meeting
  • Next meeting is on on 2018-08-20
  • As the LOINC project is on hold, we will shift to monthly Observables calls
 
7AOB   

Meeting Files

  File Modified
File testosterone_owl_el.owl 2018-Jul-11 by Daniel Karlsson
File testosterone_owl_dl.owl 2018-Jul-11 by Daniel Karlsson

Recording


More Zoom details

Topic: Observables meeting

Time: this is a recurring meeting Meet anytime

Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/992630241

Or Telephone:
Dial:
+46 (0) 8 4468 2488 (SE Toll)
+61 (0) 2 8015 2088 (AU Toll)
+32 (0) 2 588 4188 (BE Toll)
+1 647 558 0588 (CA Toll)
+56 41 256 0288 (CL Toll)
+420 2 2888 2388 (CZ Toll)
+45 89 88 37 88 (DK Toll)
+372 880 1188 (EE Toll)
+852 5808 6088 (HK Toll)
+353 (0) 1 691 7488 (IE Toll)
+972 (0) 3 978 6688 (IL Toll)
+370 5214 1488 (LT Toll)
+60 3 9212 1727 (MY Toll)
+356 2778 1288 (MT Toll)
+31 (0) 20 241 0288 (NL Toll)
+64 (0) 9 801 1188 (NZ Toll)
+64 (0) 4 831 8959 (NZ Toll)
+47 2396 0588 (NO Toll)
+48 22 307 3488 (PL Toll)
+351 308 804 188 (PT Toll)
+65 3158 7288 (SG Toll)
+421 233 056 888 (SK Toll)
+386 1888 8788 (SI Toll)
+34 91 198 0188 (ES Toll)
+41 (0) 31 528 0988 (CH Toll)
+44 (0) 20 3695 0088 (GB Toll)
+1 408 638 0968 (US Toll)
+1 646 876 9923 (US Toll)
+1 669 900 6833 (US Toll)

Meeting ID: 992 630 241

International numbers available: https://snomed.zoom.us/zoomconference?m=AQWV2VqAIGYWMcMapl9CoYjsaj1TVS7K